**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**



CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
  SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 13,
  2009

**PFIZER INC.**
  (Exact name of registrant as specified in its charter)

|**Delaware**                                                                                       | **1-3619**               | **13-5315170**                      
|-------------------------------------------------------------------------------------------------- | ------------------------ | ------------------------------------
|(State or other Jurisdiction of incorporation)                                                     | (Commission File Number) | (I.R.S. Employer Identification No.)
|**235 East 42nd Street 
          New York, New York**(Address of principal executive offices)**** |                          | **10017**
        (Zip Code)        

> Registrant's telephone number, including area code:(212) 573-2323 ****
>       (Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended
  to simultaneously satisfy the obligation of the registrant under any of the
  following provisions (see General Instruction A.2. below):

[ ] Written communication pursuant to Rule 425 under the Securities Act (17
  CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
  CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
  Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
  Act (17 CFR 240.13e-4(c))





|I**tem 5.02**                                                                                                                                                                                                                                                                                                                                                                                                   | Departure of Directors or Certain Officers; Election
        of Directors; Appointment of Certain Officers; Compensatory Arrangements
        of Certain Officers.
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------
|On January 14, 2009, Pfizer Inc. ("Pfizer") issued a press
        release announcing the election of Stephen W. Sanger to its Board of Directors,
        effective February 1, 2009. The information contained in the press release
        is deemed to be filed under the Securities Exchange Act of 1934 as Exhibit
        99 to this report, and such press release is incorporated herein by reference.



|**Item 9.01** | **Financial Statements and Exhibits** | 
|------------- | ------------------------------------- | 

|(d) Exhibits |                                                     | 
|------------ | --------------------------------------------------- | 
|99           | Press release of Pfizer Inc. dated January 14, 2009 | 



**SIGNATURE**

Under the requirements of the Securities Exchange Act of 1934, the registrant
  has caused this report to be signed on its behalf by the authorized undersigned.

|                        |  | PFIZER INC.                                                                                          
|----------------------- |  | -----------------------------------------------------------------------------------------------------
|                        |  |                                                                                                      
|                        |  | By: /s/  Lawrence A. Fox
         Lawrence A. Fox                                                    
|                        |  | Title: Vice President-Corporate Governance, Assistant General
        Counsel and Assistant Secretary
|Dated: January 14, 2009 |  |                                                                                                      

> 

EXHIBIT INDEX

|Exhibit No. | Description                                        
|----------- | ---------------------------------------------------
|99          | Press release of Pfizer Inc. dated January 14, 2009